| # | Title | Journal | Year | Citations |
|---|
| 1 | Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance | Clinical Microbiology and Infection | 2012 | 8,996 |
| 2 | Evolving epidemiology of hepatitis C virus | Clinical Microbiology and Infection | 2011 | 1,101 |
| 3 | Bacterial co-infection and secondary infection in patients with COVID-19: a living rapid review and meta-analysis | Clinical Microbiology and Infection | 2020 | 1,043 |
| 4 | ESCMID guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients | Clinical Microbiology and Infection | 2012 | 977 |
| 5 | Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline | Clinical Microbiology and Infection | 2018 | 942 |
| 6 | European Society of Clinical Microbiology and Infectious Diseases: Update of the Treatment Guidance Document for Clostridium difficile Infection | Clinical Microbiology and Infection | 2014 | 931 |
| 7 | Microbial culturomics: paradigm shift in the human gut microbiome study | Clinical Microbiology and Infection | 2012 | 905 |
| 8 | COVID-19, SARS and MERS: are they closely related? | Clinical Microbiology and Infection | 2020 | 843 |
| 9 | Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology | Clinical Microbiology and Infection | 2006 | 826 |
| 10 | Toxoplasma gondii: transmission, diagnosis and prevention | Clinical Microbiology and Infection | 2002 | 809 |
| 11 | Emergence of Clostridium difficile-associated disease in North America and Europe | Clinical Microbiology and Infection | 2006 | 738 |
| 12 | Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe | Clinical Microbiology and Infection | 2012 | 727 |
| 13 | Guidelines for the management of adult lower respiratory tract infections - Full version | Clinical Microbiology and Infection | 2011 | 721 |
| 14 | Guidelines for the validation and application of typing methods for use in bacterial epidemiology | Clinical Microbiology and Infection | 2007 | 668 |
| 15 | ESCMID guidelines for the management of the infection control measures to reduce transmission of multidrug-resistant Gram-negative bacteria in hospitalized patients | Clinical Microbiology and Infection | 2014 | 640 |
| 16 | Incidence of co-infections and superinfections in hospitalized patients with COVID-19: a retrospective cohort study | Clinical Microbiology and Infection | 2021 | 636 |
| 17 | Then and now: use of 16S rDNA gene sequencing for bacterial identification and discovery of novel bacteria in clinical microbiology laboratories | Clinical Microbiology and Infection | 2008 | 630 |
| 18 | The epidemiology and clinical manifestations of mucormycosis: a systematic review and meta-analysis of case reports | Clinical Microbiology and Infection | 2019 | 619 |
| 19 | Dutch patients, retail chicken meat and poultry share the same ESBL genes, plasmids and strains | Clinical Microbiology and Infection | 2011 | 598 |
| 20 | Listeriosis: a resurgent foodborne infection | Clinical Microbiology and Infection | 2010 | 588 |
| 21 | Real-time PCR in the microbiology laboratory | Clinical Microbiology and Infection | 2004 | 578 |
| 22 | Comparing COVID-19 vaccines for their characteristics, efficacy and effectiveness against SARS-CoV-2 and variants of concern: a narrative review | Clinical Microbiology and Infection | 2022 | 569 |
| 23 | Zygomycosis in Europe: analysis of 230 cases accrued by the registry of the European Confederation of Medical Mycology (ECMM) Working Group on Zygomycosis between 2005 and 2007 | Clinical Microbiology and Infection | 2011 | 566 |
| 24 | The negative impact of antibiotic resistance | Clinical Microbiology and Infection | 2016 | 565 |
| 25 | Determination of minimum inhibitory concentrations (MICs) of antibacterial agents by agar dilution | Clinical Microbiology and Infection | 2000 | 561 |
| 26 | ESCMID∗ guideline for the diagnosis and treatment of biofilm infections 2014 | Clinical Microbiology and Infection | 2015 | 558 |
| 27 | ESCMID† and ECMM‡ joint clinical guidelines for the diagnosis and management of mucormycosis 2013 | Clinical Microbiology and Infection | 2014 | 547 |
| 28 | Extended-spectrum β-lactamase-producing and AmpC-producing Escherichia coli from livestock and companion animals, and their putative impact on public health: a global perspective | Clinical Microbiology and Infection | 2012 | 546 |
| 29 | The difficult-to-control spread of carbapenemase producers among Enterobacteriaceae worldwide | Clinical Microbiology and Infection | 2014 | 544 |
| 30 | Emerging carbapenemases in Gram-negative aerobes | Clinical Microbiology and Infection | 2002 | 543 |
| 31 | Follow-up of adults with noncritical COVID-19 two months after symptom onset | Clinical Microbiology and Infection | 2021 | 543 |
| 32 | ESCMID guideline: diagnosis and treatment of acute bacterial meningitis | Clinical Microbiology and Infection | 2016 | 529 |
| 33 | EUCAST expert rules in antimicrobial susceptibility testing | Clinical Microbiology and Infection | 2013 | 527 |
| 34 | Rapid spread of emerging Zika virus in the Pacific area | Clinical Microbiology and Infection | 2014 | 527 |
| 35 | Development of the EUCAST disk diffusion antimicrobial susceptibility testing method and its implementation in routine microbiology laboratories | Clinical Microbiology and Infection | 2014 | 525 |
| 36 | Relationship between periodontal infections and systemic disease | Clinical Microbiology and Infection | 2007 | 519 |
| 37 | Global trends in the distribution of Candida species causing candidemia | Clinical Microbiology and Infection | 2014 | 514 |
| 38 | Antibiotic prescribing in patients with COVID-19: rapid review and meta-analysis | Clinical Microbiology and Infection | 2021 | 512 |
| 39 | Risk factors for disease severity, unimprovement, and mortality in COVID-19 patients in Wuhan, China | Clinical Microbiology and Infection | 2020 | 498 |
| 40 | Prevalence and spread of extended-spectrum β-lactamase-producing Enterobacteriaceae in Europe | Clinical Microbiology and Infection | 2008 | 495 |
| 41 | The effects of clinical and statistical heterogeneity on the predictive values of results from meta-analyses | Clinical Microbiology and Infection | 2014 | 493 |
| 42 | Bacterial and fungal coinfection among hospitalized patients with COVID-19: a retrospective cohort study in a UK secondary-care setting | Clinical Microbiology and Infection | 2020 | 492 |
| 43 | Clinical sequelae of COVID-19 survivors in Wuhan, China: a single-centre longitudinal study | Clinical Microbiology and Infection | 2021 | 492 |
| 44 | Infections due to emerging and uncommon medically important fungal pathogens | Clinical Microbiology and Infection | 2004 | 488 |
| 45 | Efflux-mediated multiresistance in Gram-negative bacteria | Clinical Microbiology and Infection | 2004 | 476 |
| 46 | Lyme borreliosis: Clinical case definitions for diagnosis and management in Europe | Clinical Microbiology and Infection | 2011 | 474 |
| 47 | Overall burden of bloodstream infection and nosocomial bloodstream infection in North America and Europe | Clinical Microbiology and Infection | 2013 | 469 |
| 48 | Pseudomonas aeruginosa: resistance and therapeutic options at the turn of the new millennium | Clinical Microbiology and Infection | 2007 | 455 |
| 49 | Promoting resistance by the emission of antibiotics from hospitals and households into effluent | Clinical Microbiology and Infection | 2003 | 452 |
| 50 | Mucormycosis and entomophthoramycosis: a review of the clinical manifestations, diagnosis and treatment | Clinical Microbiology and Infection | 2004 | 452 |
